南京市栖霞区仙林大道163号南京大学生命科学学院
qiongluo@nju.edu.cn
工作经历
2025-，南京大学生命科学学院准聘副教授（特聘研究员）
2024-2025，南京大学生命科学学院准聘助理教授（特聘研究员）
2016-2024, 南京大学生命科学学院 特任副研究员
2013-2016, 南京大学生命科学学院 特任助理研究员
荣誉奖励
2024年江苏省自然科学百篇优秀学术成果论文
2023年度江苏省行业领域优秀科技进展（生物医药领域）
学术任职
中国药理学会抗炎免疫药理专业委员会第十三届委员会委员
中国药理学会抗炎免疫药理专业委员会第二届青年委员会常务委员
江苏省整合医学研究会第二届理事
代表性成果
[1] Xuecheng Shen, Wenxuan Qiao, Wei Yan, Hao Xie, Chenyang Zhang, Yang Sun, Qiong Luo#, Qiang Xu#. Keratinocyte-specific H4K12 lactylation drives a non-canonical IL-17-dependent signaling in psoriasis progression in mice. Nature Communications, 2025, 16(1):8639.
[2] Ya-qi Yang, Yi-jun Liu, Wen-xuan Qiao, Wei Jin, Shun-wei Zhu, Yu-xi Yan, Qiong Luo#, Qiang Xu#. Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren's syndrome in mice by promoting TEC kinase degradation, Acta Pharmacologica Sinica, 2024, 45(9):1926-1936.
[3] Qiong Luo#, Yijun Liu, Ke Shi, Xuecheng Shen, Yaqi Yang, Xuejiao Liang, Liangliang Lu, Wenxuan Qiao, Airu Chen, Dongmei Hong, Yang Sun, Qiang Xu#. An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression, Immunity, 2023, 56(9): 2006-2020.
[4] Xuejiao Liang, Ningxin Wang, Quanyao Yang, Xuecheng Shen, Wenxuan Qiao, Qiang Xu#, Qiong Luo#. Inhibition of CDC25C attenuates IL-17A-driven keratinocyte hyperproliferation and psoriasis progression. Biochem Biophys Res Commun. 2026 Feb 26;802:153342.
[5] Xuejiao Liang, Liangliang Lu, Ningxin Wang, Biao Yu, Qiang Xu#, Qiong Luo#. SBF-1 suppresses colorectal cancer cell growth via modulating cholesterol metabolic reprogramming. Biochem Biophys Res Commun. 2026 Jan 1;794:153046.
[6] Ke Shi, Yunlong Shan, Xiao Sun, Kuida Chen, Qiong Luo#, Qiang Xu#. TP53INP2 modulates the malignant progression of colorectal cancer by reducing the inactive form of β-catenin. Biochem Biophys Res Commun. 2024 Jan 1,690:149275.
[7] Yunlong Shan, Yuan Gao, Wei Jin, Minmin Fan, Ying Wang, Yanhong Gu, Chenxiao Shan, Lijun Sun, Xin Li, Biao Yu, Qiong Luo#, Qiang Xu#. Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer, Cell Death & Disease, 2019, 10(8): 618-618.